sglt2 glp-1 news Inhibitors and Receptor Agonists in Cardiovascular–Kidney–Metabolic Syndrome SGLT2 vs GLP-1: Individualizing Diabetes,

Glucagon-like peptide-1 receptor agonists (GLP-1) are drugs utilized to treat diabetes, but they are also approved as an adjunct to a low-calorie diet to reduce body weight and to enhance the metabolic profile readings for diabetic and non-diabetic patients

If you have diabetes, work with a nutritionist or another health specialist to manage your blood sugar levels through medication, diet, exercise, and regular monitoring

It lowers blood glucose and increases insulin sensitivity, thereby reducing insulin resistance

Are you taking your injections consistently

The primary endpoint (a composite of death from CV causes, nonfatal MI, or nonfatal stroke) occurred in 6.5% of the semaglutide group vs